Divalproex sodium: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Blanked the page)
No edit summary
Line 1: Line 1:
{{DrugProjectFormSinglePage
|authorTag={{PB}}
|genericName=Divalproex  sodium
|aOrAn=a
|drugClass=mood stabilizer
|blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b>
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)
|offLabelAdultGuideSupport=There is limited information about <i>Off-Label Guideline-Supported Use</i> of Divalproex sodium in adult patients.
|offLabelAdultNoGuideSupport=There is limited information about <i>Off-Label Non–Guideline-Supported Use</i> of Divalproex sodium in adult patients.
|offLabelPedGuideSupport=There is limited information about <i>Off-Label Guideline-Supported Use</i> of Divalproex sodium in pediatric patients.
|offLabelPedNoGuideSupport=There is limited information about <i>Off-Label Non–Guideline-Supported Use</i> of Divalproex sodium in pediatric patients.
|drugBox={{Infobox drug
| drug_name = Valproate semisodium
| IUPAC_name = sodium 2-propylpentanoic acid 2-propylpentanoate
| image = Valproate-semisodium2DACS.svg
| width = 200px


<!-- Clinical data -->
| tradename = Depakote
| Drugs.com = {{drugs.com|mtm|divalproex-sodium}}
| MedlinePlus = a682412
| pregnancy_AU =
| pregnancy_category = D, X (US; depends on its indication)
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = Oral
<!-- Pharmacokinetic data -->
| bioavailability =
| protein_bound = 10-18.5% (dose-dependent)
| metabolism = Hepatic (30-50% via glucuronidation; 40% via β-oxidation & 15-20% via other oxidative pathways)
| elimination_half-life = 9-16 hours (dose-dependent)
| excretion = Renal (<3% unchanged)
<!-- Identifiers -->
| PubChem = 23663956
| ChemSpider = 48337
<!-- Chemical data-->
| chemical_formula =
| C=16 | H=31 | Ag= | Al= | As= | Au= | B= | Bi= | Br= | Ca= | Cl= | Co= | F= | Fe= | Gd= | I=
| K= | Li= | Mg= | Mn= | N= | Na=1 | O=4 | P= | Pt= | S= | Sb= | Se= | Sr= | Tc= | Zn= | charge=
}}
|alcohol=Alcohol-Divalproex sodium interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
}}

Revision as of 20:30, 26 May 2014

Divalproex sodium
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Divalproex sodium is a mood stabilizer that is FDA approved for the {{{indicationType}}} of {{{indication}}}. Common adverse reactions include {{{adverseReactions}}}.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

There is limited information regarding Divalproex sodium FDA-Labeled Indications and Dosage (Adult) in the drug label.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information about Off-Label Guideline-Supported Use of Divalproex sodium in adult patients.

Non–Guideline-Supported Use

There is limited information about Off-Label Non–Guideline-Supported Use of Divalproex sodium in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Divalproex sodium FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information about Off-Label Guideline-Supported Use of Divalproex sodium in pediatric patients.

Non–Guideline-Supported Use

There is limited information about Off-Label Non–Guideline-Supported Use of Divalproex sodium in pediatric patients.

Contraindications

There is limited information regarding Divalproex sodium Contraindications in the drug label.

Warnings

There is limited information regarding Divalproex sodium Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Divalproex sodium Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Divalproex sodium Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Divalproex sodium Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Divalproex sodium in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Divalproex sodium in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Divalproex sodium during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Divalproex sodium in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Divalproex sodium in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Divalproex sodium in geriatric settings.

Gender

There is no FDA guidance on the use of Divalproex sodium with respect to specific gender populations.

Race

There is no FDA guidance on the use of Divalproex sodium with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Divalproex sodium in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Divalproex sodium in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Divalproex sodium in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Divalproex sodium in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Divalproex sodium Administration in the drug label.

Monitoring

There is limited information regarding Divalproex sodium Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Divalproex sodium and IV administrations.

Overdosage

There is limited information regarding Divalproex sodium overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

Valproate semisodium
File:Valproate-semisodium2DACS.svg
Clinical data
Trade namesDepakote
AHFS/Drugs.comMultum Consumer Information
MedlinePlusa682412
Pregnancy
category
  • D, X (US; depends on its indication)
Routes of
administration		Oral
Legal status
Legal status
Pharmacokinetic data
Protein binding10-18.5% (dose-dependent)
MetabolismHepatic (30-50% via glucuronidation; 40% via β-oxidation & 15-20% via other oxidative pathways)
Elimination half-life9-16 hours (dose-dependent)
ExcretionRenal (<3% unchanged)
Identifiers
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H31NaO4
Molar mass310.41 g·mol−1

Mechanism of Action

There is limited information regarding Divalproex sodium Mechanism of Action in the drug label.

Structure

There is limited information regarding Divalproex sodium Structure in the drug label.

Pharmacodynamics

There is limited information regarding Divalproex sodium Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Divalproex sodium Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Divalproex sodium Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Divalproex sodium Clinical Studies in the drug label.

How Supplied

There is limited information regarding Divalproex sodium How Supplied in the drug label.

Storage

There is limited information regarding Divalproex sodium Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Divalproex sodium |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Divalproex sodium |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Divalproex sodium Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Divalproex sodium interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Divalproex sodium Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Divalproex sodium Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

Retrieved from "https://www.wikidoc.org/index.php?title=Divalproex_sodium&oldid=973576"